In the BioHarmony Drug Report Database

"Preview" Icon

Dalfopristin

Synercid (dalfopristin) is a small molecule pharmaceutical. Dalfopristin was first approved as Synercid on 1999-09-21. It is used to treat bacterial infections, staphylococcal skin infections, and streptococcal infections in the USA.

 

Trade Name

 

Synercid
 

Common Name

 

dalfopristin
 

ChEMBL ID

 

CHEMBL1200937
 

Indication

 

bacterial infections, staphylococcal skin infections, streptococcal infections
 

Drug Class

 

Antibacterials, pristinamycin derivatives

Image (chem structure or protein)

Dalfopristin structure rendering